C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 473/06 (2006.01) A61K 31/522 (2006.01) A61P 3/10 (2006.01) A61P 9/12 (2006.01) A61P 11/06 (2006.01) C07D 473/08 (2006.01)
Patent
CA 2718983
Compounds of the present disclosure are fused pyrimidine compounds of formula (I), its tautomers, polymorphs, stereoisomers, prodrugs, solvate or a pharmaceutically acceptable salts thereof, as Adenosine receptor antagonists. Processes of their preparation are also described in the disclosure.
L'invention concerne des composés de pyrimidine fusionnés représentés par la formule (I), des tautomères, polymorphes, stéréoisomères, promédicaments, un solvate ou des sels pharmaceutiquement acceptables de ceux-ci, qui constituent des antagonistes des récepteurs adénosiniques. Des procédés de préparation de ces composés sont également décrits.
Barawkar Dinesh
Basu Sujay
Palle Venkata
Panmand Anil
Patel Meena
Advinus Therapeutics Pvt. Ltd.
Smart & Biggar
LandOfFree
Heterocyclic compounds as adenosine receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds as adenosine receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds as adenosine receptor antagonist will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1350509